BLUE Stock Price, Chart, Stats & News
bluebird bio, Inc. (BLUE) does not currently pay a dividend.
BLUE chart
Price history is unavailable
We don't have enough price data for BLUE to draw a chart yet.
Fundamentals
Gross margin | 46.72% |
Operating margin | -145.69% |
Pretax margin | -134.83% |
Net margin | -135.00% |
Effective tax rate | -0.13% |
ROA | -40.07% |
ROE | 373.76% |
D/E | -3.25x |
Interest coverage ratio | -7.43x |
BLUE valuation
P/E | – |
P/S | 0.55x |
P/B | -0.84x |
P/CF | -0.30x |
P/FCF | -0.30x |
P/OCF | -0.30x |
PEG | 0.01x |
EV multiple | 1.08x |
About
bluebird bio, Inc. is a biotechnology firm that concentrates on the discovery, development, and commercialization of innovative gene therapies. These pioneering treatments are aimed at debilitating genetic conditions. Among its leading investigational therapies for severe inherited diseases are betibeglogene autotemcel (beti-cel), intended for patients with transfusion-dependent beta-thalassemia; lovotibeglogene autotemcel (lovo-cel), which targets sickle cell disease (SCD); and elivaldogene autotemcel (eli-cel), developed to address cerebral adrenoleukodystrophy.
Similar securities
Based on sector and market capitalization
